Sun Pharma launches ready-to-infuse INFUGEM in the US
INFUGEM (gemcitabine in sodium chloride injection) is the first and only chemotherapy product in a premixed, ready-to-infuse…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Purdue’s Sackler family fights ‘inflammatory’ Massachusetts opioid case
The case is among roughly 2,000 lawsuits filed mostly by state and local governments seeking to hold Purdue and other…
Japan’s Takeda invites Brazilian pharmaceutical firms to bid for Latam business: Sources
Takeda expects to fetch more than $1 billion for the Latin American operations. In Brazil, Takeda owns popular over the counter…
Pharma leaders discuss strategies thrive in an era of disruption
Industry captains come together at a select meet organised by Express Pharmaand Optel Group in Mumbai to chart the progress of the…
‘One should always buy generic medicines from reliable brands or outlets’
Having an idea to serve the populace with inexpensive but effective medicine, StayHappi Pharmacy wants to reach as many people as…
Servier joins Access Accelerated to fight against non-communicable diseases
Now consisting of 26 pharmaceutical companies, Access Accelerated unites industry action and applies member companies' global…
Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA
Lupin’s Pithampur Unit-3 is involved in the manufacture of Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Topical…
Exports in March to reach $32.38 billion: Suresh Prabhu
Exports will cross the $331-billion mark in the year 2018-19, Commerce and Industry Minister said
Aurobindo Pharma, Lupin recall drugs in US market
The USFDA has classified the action for Aurobindo Pharma as a Class II recall, and for Lupin, the health regulator classified the…
Biocon to soon expand its presence in biosimilars in US market
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs